【投融资动态】玄薇医疗种子轮融资，投资方为梅花创投

Core Viewpoint - Beijing Xuanwei Biomedical Technology Co., Ltd. has completed a seed round of financing, focusing on precision medicine in oncology, with investment participation from Meihua Venture Capital [1] Company Overview - Xuanwei Medical is an innovative technology company dedicated to the field of tumor precision medicine, positioning itself with "AI-enabled precision medicine" as its core focus [1] - The company's mission is to "data-driven optimize tumor treatment and clinical practice," specifically addressing the critical pain point of toxic reactions in tumor immunotherapy [1] - Xuanwei Medical aims to become a leading provider of specialized tumor data and intelligent auxiliary diagnosis and treatment services in China [1]